Nevro Corp Stock Analysis
NVRO Stock | USD 5.78 0.01 0.17% |
Nevro Corp is undervalued with Real Value of 6.82 and Target Price of 5.6. The main objective of Nevro Corp stock analysis is to determine its intrinsic value, which is an estimate of what Nevro Corp is worth, separate from its market price. There are two main types of Nevro Corp's stock analysis: fundamental analysis and technical analysis.
The Nevro Corp stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Nevro Corp is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Nevro Stock trading window is adjusted to America/New York timezone.
Nevro |
Nevro Stock Analysis Notes
About 97.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.96. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Nevro Corp recorded a loss per share of 3.06. The entity had not issued any dividends in recent years. The firm had 1:24 split on the 6th of November 2014. Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California. Nevro Corp operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 945 people. To find out more about Nevro Corp contact DKeith Grossman at 650 251 0005 or learn more at https://nevro.com.Nevro Corp Quarterly Total Revenue |
|
Nevro Corp Investment Alerts
Nevro Corp appears to be risky and price may revert if volatility continues | |
The company reported the previous year's revenue of 408.52 M. Net Loss for the year was (113.44 M) with profit before overhead, payroll, taxes, and interest of 269.53 M. | |
Nevro Corp currently holds about 310.82 M in cash with (19.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Over 97.0% of the company shares are owned by institutional investors | |
Latest headline from zacks.com: Disposition of 1143 shares by Roderick MacLeod of Nevro Corp at 5.72 subject to Rule 16b-3 |
Nevro Corp Upcoming and Recent Events
Earnings reports are used by Nevro Corp to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
21st of February 2024 Upcoming Quarterly Report | View | |
24th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
15th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Nevro Largest EPS Surprises
Earnings surprises can significantly impact Nevro Corp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2018-08-02 | 2018-06-30 | -0.31 | -0.35 | -0.04 | 12 | ||
2023-02-16 | 2022-12-31 | -0.49 | -0.54 | -0.05 | 10 | ||
2018-11-05 | 2018-09-30 | -0.29 | -0.37 | -0.08 | 27 |
Nevro Corp Environmental, Social, and Governance (ESG) Scores
Nevro Corp's ESG score is a quantitative measure that evaluates Nevro Corp's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Nevro Corp's operations that may have significant financial implications and affect Nevro Corp's stock price as well as guide investors towards more socially responsible investments.
Nevro Corp Thematic Classifications
In addition to having Nevro Corp stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | Obamacare RepealLarge healthcare related equities associated with Obamacare | |
![]() | Medical EquipmentUSA Equities from Medical Equipment industry as classified by Fama & French |
Nevro Stock Institutional Investors
Shares | State Street Corp | 2024-12-31 | 769.9 K | Palo Alto Investors, Llc | 2024-12-31 | 750.4 K | Assenagon Asset Management Sa | 2024-12-31 | 670.8 K | Jacobs Levy Equity Management, Inc. | 2024-12-31 | 661.7 K | Western Standard Llc | 2024-12-31 | 645.1 K | Citadel Advisors Llc | 2024-12-31 | 598.9 K | Jpmorgan Chase & Co | 2024-12-31 | 506.4 K | Goldman Sachs Group Inc | 2024-12-31 | 455.1 K | Jefferies Financial Group Inc | 2024-12-31 | 441.9 K | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-12-31 | 4.4 M | Armistice Capital, Llc | 2024-12-31 | 3.7 M |
Nevro Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 221.79 M.Nevro Profitablity
The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.22) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.22.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.21) | (0.22) | |
Return On Capital Employed | (0.28) | (0.29) | |
Return On Assets | (0.20) | (0.22) | |
Return On Equity | (0.49) | (0.52) |
Management Efficiency
Nevro Corp has return on total asset (ROA) of (0.0995) % which means that it has lost $0.0995 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4329) %, meaning that it created substantial loss on money invested by shareholders. Nevro Corp's management efficiency ratios could be used to measure how well Nevro Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of March 2025, Return On Tangible Assets is likely to drop to -0.22. In addition to that, Return On Capital Employed is likely to drop to -0.29. At this time, Nevro Corp's Non Current Assets Total are very stable compared to the past year. As of the 20th of March 2025, Intangible Assets is likely to grow to about 25.6 M, while Total Assets are likely to drop about 473.1 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 6.23 | 5.92 | |
Tangible Book Value Per Share | 5.57 | 5.29 | |
Enterprise Value Over EBITDA | (2.33) | (2.45) | |
Price Book Value Ratio | 0.60 | 0.57 | |
Enterprise Value Multiple | (2.33) | (2.45) | |
Price Fair Value | 0.60 | 0.57 | |
Enterprise Value | 294.6 M | 279.9 M |
The strategic initiatives led by Nevro Corp's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Technical Drivers
As of the 20th of March, Nevro Corp secures the Mean Deviation of 2.64, risk adjusted performance of 0.1124, and Downside Deviation of 3.69. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nevro Corp, as well as the relationship between them.Nevro Corp Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nevro Corp middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nevro Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Nevro Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nevro Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nevro Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nevro Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nevro Corp Outstanding Bonds
Nevro Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nevro Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nevro bonds can be classified according to their maturity, which is the date when Nevro Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Nevro Corp Predictive Daily Indicators
Nevro Corp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nevro Corp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Nevro Corp Corporate Filings
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10th of March 2025 Other Reports | ViewVerify | |
8K | 4th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
21st of February 2025 Other Reports | ViewVerify | |
20th of February 2025 Other Reports | ViewVerify | |
14th of February 2025 Other Reports | ViewVerify | |
8K | 6th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 27th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Nevro Corp Forecast Models
Nevro Corp's time-series forecasting models are one of many Nevro Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nevro Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Nevro Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Nevro Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nevro shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nevro Corp. By using and applying Nevro Stock analysis, traders can create a robust methodology for identifying Nevro entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.28) | (0.29) | |
Operating Profit Margin | (0.31) | (0.32) | |
Net Loss | (0.28) | (0.29) | |
Gross Profit Margin | 0.66 | 0.53 |
Current Nevro Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nevro analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nevro analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
5.6 | Hold | 16 | Odds |
Most Nevro analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nevro stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nevro Corp, talking to its executives and customers, or listening to Nevro conference calls.
Nevro Stock Analysis Indicators
Nevro Corp stock analysis indicators help investors evaluate how Nevro Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Nevro Corp shares will generate the highest return on investment. By understating and applying Nevro Corp stock analysis, traders can identify Nevro Corp position entry and exit signals to maximize returns.
Begin Period Cash Flow | 104.8 M | |
Total Stockholder Equity | 231 M | |
Capital Lease Obligations | 25.5 M | |
Property Plant And Equipment Net | 47.7 M | |
Cash And Short Term Investments | 292.5 M | |
Net Invested Capital | 456.6 M | |
Cash | 94.5 M | |
50 Day M A | 5.2428 | |
Net Interest Income | -13.6 M | |
Total Current Liabilities | 102.9 M | |
Investments | 14.6 M | |
Interest Expense | 26.9 M | |
Stock Based Compensation | 51.2 M | |
Long Term Debt | 187.7 M | |
Common Stock Shares Outstanding | 37.1 M | |
Tax Provision | 1.1 M | |
Free Cash Flow | -29.2 M | |
Other Current Assets | 8.3 M | |
Accounts Payable | 24.5 M | |
Net Debt | 156.6 M | |
Other Operating Expenses | 534.7 M | |
Non Current Assets Total | 77.8 M | |
Liabilities And Stockholders Equity | 553.8 M | |
Non Currrent Assets Other | 5.7 M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nevro Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.06) | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets | Return On Equity |
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.